These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
286 related articles for article (PubMed ID: 22620019)
21. Sporadic inclusion-body myositis: Recent advances and the state of the art in 2016. Gallay L; Petiot P Rev Neurol (Paris); 2016 Oct; 172(10):581-586. PubMed ID: 27616487 [TBL] [Abstract][Full Text] [Related]
23. The association of sporadic inclusion body myositis and Sjögren's syndrome in carriers of HLA-DR3 and the 8.1 MHC ancestral haplotype. Rojana-udomsart A; Needham M; Luo YB; Fabian V; Walters S; Zilko PJ; Mastaglia FL Clin Neurol Neurosurg; 2011 Sep; 113(7):559-63. PubMed ID: 21507567 [TBL] [Abstract][Full Text] [Related]
24. Challenges in diagnosis and treatment of sporadic inclusion-body myositis. Sebastian A; Misterska-Skóra M; Sebastian M; Kręcichwost R; Haczkiewicz K Adv Clin Exp Med; 2018 Oct; 27(10):1453-1457. PubMed ID: 30088352 [TBL] [Abstract][Full Text] [Related]
25. High prevalence of inclusion body myositis in Norway; a population-based clinical epidemiology study. Dobloug GC; Antal EA; Sveberg L; Garen T; Bitter H; Stjärne J; Grøvle L; Gran JT; Molberg Ø Eur J Neurol; 2015 Apr; 22(4):672-e41. PubMed ID: 25530508 [TBL] [Abstract][Full Text] [Related]
27. Inclusion body myositis: current pathogenetic concepts and diagnostic and therapeutic approaches. Needham M; Mastaglia FL Lancet Neurol; 2007 Jul; 6(7):620-31. PubMed ID: 17582362 [TBL] [Abstract][Full Text] [Related]
28. Upregulated inducible co-stimulator (ICOS) and ICOS-ligand in inclusion body myositis muscle: significance for CD8+ T cell cytotoxicity. Schmidt J; Rakocevic G; Raju R; Dalakas MC Brain; 2004 May; 127(Pt 5):1182-90. PubMed ID: 15047591 [TBL] [Abstract][Full Text] [Related]
29. Sporadic inclusion body myositis--diagnosis, pathogenesis and therapeutic strategies. Dalakas MC Nat Clin Pract Neurol; 2006 Aug; 2(8):437-47. PubMed ID: 16932602 [TBL] [Abstract][Full Text] [Related]
30. Sporadic inclusion body myositis - a myodegenerative disease or an inflammatory myopathy. Weihl CC; Mammen AL Neuropathol Appl Neurobiol; 2017 Feb; 43(1):82-91. PubMed ID: 28111778 [TBL] [Abstract][Full Text] [Related]
31. Epidemiology of sporadic inclusion body myositis and polymyositis in Olmsted County, Minnesota. Wilson FC; Ytterberg SR; St Sauver JL; Reed AM J Rheumatol; 2008 Mar; 35(3):445-7. PubMed ID: 18203321 [TBL] [Abstract][Full Text] [Related]
32. Demographic features of Japanese patients with sporadic inclusion body myositis: a single-center referral experience. Nakanishi H; Koike H; Matsuo K; Tanaka F; Noda T; Fujikake A; Kimura S; Katsuno M; Doyu M; Watanabe H; Sobue G Intern Med; 2013; 52(3):333-7. PubMed ID: 23370740 [TBL] [Abstract][Full Text] [Related]
33. [Inclusion-body myositis]. Benveniste O Rev Med Interne; 2014 Jul; 35(7):472-9. PubMed ID: 24128435 [TBL] [Abstract][Full Text] [Related]
34. Sporadic inclusion body myositis presenting with severe camptocormia. Ma H; McEvoy KM; Milone M J Clin Neurosci; 2013 Nov; 20(11):1628-9. PubMed ID: 24055211 [TBL] [Abstract][Full Text] [Related]
35. Magnetic resonance imaging of skeletal muscles in sporadic inclusion body myositis. Cox FM; Reijnierse M; van Rijswijk CS; Wintzen AR; Verschuuren JJ; Badrising UA Rheumatology (Oxford); 2011 Jun; 50(6):1153-61. PubMed ID: 21288962 [TBL] [Abstract][Full Text] [Related]